C.R. BARD, INC. (COVINGTON)

Manufacturer adverse-event records for C.R. BARD, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2004–2023 · thin-book · quiet Death-code · injury-heavy

Injury-mix signature

C.R. BARD, INC. leans injury-heavy in event_type mix

Injury-coded event_type share is 97.9% (injury-heavy tercile) beside 0.00% Death-coded (quiet). Volume band: thin.

What the Injury-mix reading shows for C.R. BARD, INC. (COVINGTON)

The standout signal for C.R. BARD, INC. (COVINGTON) is Injury-mix: 97.9% Injury-coded (injury-heavy) beside 0.00% Death-coded, on a thin-book footprint.

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Injury at 5,501 (97.9% of event_type total). Peak single-year volume reaches 4,933 reports across 11 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

5,619
Total Reports
0
Event-type Death
5,501
Injury Reports
20
Device Types

Event Types

Injury 5,501 (97.9%)
Malfunction 61 (1.1%)
51 (0.9%)
Other 6 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 5,539 (86.7%)
S 771 (12.1%)
71 (1.1%)
Other 6 (0.1%)
R 2 (0.0%)
Disability 2 (0.0%)
Hospitalization 1 (0.0%)

Yearly Trend

04
2004: 1
12
2012: 605
13
2013: 4,933
14
2014: 37
15
2015: 34
17
2017: 1
18
2018: 1
19
2019: 4
20
2020: 1
22
2022: 1
23
2023: 1